Homozygous CDA*3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patients
- H. Ueno
- , N. Kaniwa
- , T. Okusaka
- , M. Ikeda
- , C. Morizane
- , S. Kondo
- , E. Sugiyama
- , S. R. Kim
- , R. Hasegawa
- , Y. Saito
- , T. Yoshida
- , N. Saijo
- , J. Sawada
Research output: Contribution to journal › Article › peer-review
54
Scopus
citations